Peter Myers Digest: Ivermectin and HCQ

Melbourne doctors defy TGA; South Africa bans Ivermectin; India sends HCQ to Africa - posts by Meryl Nass, M.D.Regulators' bans on HCQ & Ivermectin show that the real goal is Agenda ID2020 - Peter Koenig (item 12).
(1) Melbourne doctors defy TGA, under investigation for promoting HCQ & Ivermectin(2) Ivermectin prophylaxis and early outpatient treatment; studies from many countries(3) South Africa bans Ivermectin; India sends HCQ to Africa - posts by Meryl Nass, M.D.(4) South African doctors call for Ivermectin to be authorised(5) Hydroxychloroquine is why Uganda, with a population of 43M, has only 15 COVID-19 deaths(6) India sends HCQ to Africa in war on coronavirus(7) African countries conduct Covid trial, including HCQ(8) More than 30 trials across the world show Ivermectin effective against Covid(9) 'If we use Ivermectin widely, our societies can open up' - Professor Paul Marik(10) Interferon stops Covid(11) Medical Trial: Cheap Asthma Inhalers 90% Reduction in Severe Covid Symptoms(12) Beware of RNA-based Vaccines. Potentially Serious Injuries. The Risk of Prion Disease(13) India's low Covid mortality rate, only 35% of the global average
(1) Melbourne doctors defy TGA, under investigation for promoting HCQ & IvermectinFrom: Matthew Mitchell <>profile:,197 doctors under review for promoting discredited Covid treatmentThe drug regulator says a group of doctors is being investigated for promoting hydroxychloroquine as a treatment for the virus, against all scientific evidenceA medical worker in full protective suit holding hydroxychloroquine tabletsAustralia's TGA has not approved hydroxychloroquine as a Covid treatment, meaning doctors are breaking the law if they prescribe it for that purpose. Photograph: AlexSava/Getty ImagesMargaret Simons@MargaretSimonsMon 22 Feb 2021 03.30 AEDTTrust the experts, we are told. Believe the science. But what happens when it is a group of eminent doctors who are behind the misinformation – and they back their claims with a superficially convincing bevy of peer-reviewed academic journal articles?These are the questions raised by the existence of the Covid Medical Network – a company run by three Melbourne doctors that has been promoting the use of hydroxychloroquine as a treatment for Covid-19 in defiance of the public health authorities, the World Health Organization and most expert medical opinion.The CMN also casts doubt on the reliability of tests for Covid – because they only tell you whether you are positive or negative for the presence of the virus, not whether you are infectious – as well as the need for and efficacy of the vaccines, and says wearing masks can be harmful to your health.Australia's medical goods regulator, the Therapeutic Goods Administration, has told the Guardian that the doctors are "under review" for possible breaches of consumer laws and the Therapeutic Goods Advertising Code that prohibit misleading advertising and advertising of prescription medicines. This is because the CMN promotes a cocktail of prescription drugs – including hydroxychloroquine and ivermectin – that are not approved for use to treat Covid-19 . The penalties can be severe.As this article was being prepared, the CMN took down some of the material promoting hydroxychloroquine after a "formal cease and desist" letter from the TGA."We are currently consulting with our lawyers and the TGA regarding how best to provide the information in a manner that would not reasonably be construed as advertising the medications associated with the safe and effective treatment of early Covid illness," the website said.The doctors behind the CMN are practising regularly in Melbourne, including in aged care and our leading public and private hospitals.The network does not believe it is disseminating misinformation but rather that it is performing a public service – putting out information it sees as backed by evidence. It claims "widely available international evidence and experience, which is now readily available" will eventually see medical authorities move to their position, which they describe as "now virtually beyond dispute".The CMN – or at least its leader, Dr Eamonn Mathieson – suggests that Australian and world health authorities are negligent in failing to keep up with the most recent research and guilty of "therapeutic nihilism" and malpractice in preventing sick people from being properly treated.The CMN even invokes the name of that favourite target of US conspiracy theorists, billionaire Bill Gates, suggesting that Australian medical authorities should be regarded with suspicion because they have participated in research funded by the Gates Foundation.Craig KellyLiberal MP Craig Kelly has praised US doctor Vladimir Zelenko, who promoted the use of hydroxychloroquine. Photograph: Mike Bowers/The GuardianAdvertisementA recent CMN webinar includes the Liberal MP Craig Kelly interviewing American doctor Vladimir Zelenko, whose claim early in the pandemic to have successfully treated Covid patients with hydroxychloroquine was the inspiration for then president Donald Trump's promotion of the drug."I consider you a true hero sir," Kelly says to Zelenko – who has been banned by social media companies for spreading misinformation and criticised by the orthodox Jewish community in which he practised for allegedly exaggerating infection rates.The interview was posted on 10 February – eight days after the prime minister, Scott Morrison, claimed to have "dressed down" Kelly for spreading Covid misinformation. At the time of writing it remains on the website, despite the TGA action.Meanwhile, numerous interviews on Sky News with medical practitioners promoting hydroxychloroquine and criticising health authorities are claimed to have been "coordinated" by the CMN.Doctors against Melbourne lockdownThe CMN came to prominence during Melbourne's second wave of Covid infections when it organised an open letter, eventually endorsed by 500 doctors, asserting that government-imposed lockdowns were a greater threat to health than the virus, and calling for them to be immediately lifted.Several of the doctors who signed the letter have told the Guardian that while they stood by their statements, they do not support other material on the CMN website, and in particular its promotion of hydroxychloroquine.Prof Ben Mol is a specialist in obstetrics and gynaecology at the University of Adelaide. He said he agreed to sign the letter only after he had struck out a paragraph that promoted hydroxychloroquine. "It is just not true … it is clear that not only is hydroxychloroquine not effective but it is potentially harmful," he says.Mol says he is now worried by the material on the CMN website – while also being critical of some government information and the public health response to the pandemic more broadly. "I try to find a middle path."A few weeks after the letter was published, CMN was established as a not-for-profit company with three prominent Melbourne doctors as directors.The head of the group is Mathieson, an anaesthetist with a practice in Heidelberg who also works at the Mercy Hospital for Women and a range of Melbourne's leading private hospitals.Mathieson also heads the Australian Catholic Medical Association, which has campaigned against the banning of gay conversion therapy and the legalisation of euthanasia. In August last year, the association wrote to Morrison opposing the use of "aborted fetal cell lines" in Covid vaccines. ...(2) Ivermectin prophylaxis and early outpatient treatment; studies from many countries Prophylaxis & Early Outpatient Treatment Protocol for COVID-19In October 2020, the FLCCC Alliance developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+. It's centered around ivermectin, a well-known, FDA-approved anti-parasite drug that has been used successfully for more than four decades to treat onchocerciasis "river blindness" and other parasitic diseases. It is one of the safest drugs known. It is on the WHO's list of essential medicines, has been given 3.7 billion times around the globe, and has won the Nobel prize for its global and historic impacts in eradicating endemic parasitic infections in many parts of the world. Our medical discovery of a rapidly growing published medical evidence base, demonstrating ivermectin's unique and highly potent ability to inhibit SARS-CoV-2 replication and to suppress inflammation, prompted our team to use ivermectin for prevention and treatment in all stages of COVID-19. Ivermectin is not yet FDA-approved for the treatment of COVID-19, but on Jan 14, 2021, the NIH changed their recommendation for the use of ivermectin in COVID-19 from "against" to "neutral". (see our press release).Our life-saving MATH+ Hospital Treatment Protocol for COVID-19 (available in several languages), created in March 2020, is intended for hospitalized patients. The recently developed I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 (this page) is designed for use as a prophylaxis and in early outpatient treatment, for those who test positive for COVID-19. The protocols complement each other, and both are physiologic-based combination treatment regimens developed by leaders in critical care medicine. All the component medicines are FDA-approved (except ivermectin), inexpensive, readily available and have been used for decades with well-established safety profiles.Please download and share our I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19. (It is currently being translated into several languages).Below are a list of links to our one-page summary of the latest evidence for the protocol, plus videos of FLCCC Alliance doctors discussing the emerging evidence for the use of ivermectin in the prophylaxis and treatment of COVID-19, and a short list of up-to-date studies and clinical trials on this topic.Publications and videos on the use of ivermectin in our I-MASK+ protocolOur comprehensive review of the emerging evidence for ivermectin use in our I-MASK+ protocolA one-page summary of the scientific review on ivermectin aboveDr. Paul Marik's comprehensive meta-analysis of COVID-19 therapeuticsAn introductory video explaining the review on ivermectin by Dr. Pierre KoryDr. Paul Marik's recent lecture on I-MASK+Invited Grand Rounds Lecture on ivermectin by Pierre KoryPlease also regard Dr. Paul Marik's latestAn FLCCC Alliance guide to the management of COVID-19 – An overview of the MATH+ and I-MASK+ protocolsRecent studies and clinical trials on ivermectinNovember 16, 2020 | EgyptEfficacy and safety of ivermectin for treatment and prophylaxis of COVID-19 pandemicElgazzar A, Basma H, Shaimaa Abo Y, Basma H, Mohy H, Hany M (Research Square; 100956) 3, 2020 | IndiaRole of Ivermectin in the prevention of COVID-19 infection among health care workers in IndiaA matched case-control study; Behera P, Patro BK, Singh AK, et al. (medRxiv) 27, 2020 | IraqControlled randomized clinical trial on using ivermectin with doxycycline for treating COVID-19 patients in Baghdad, IraqHashim HA, Maulood MF, Rasheed AM, Fatak DF, Kabah KK, Abdulamir AS (medRxiv) 22 | PeruAntiviral and anti-inflammatory properties of ivermectin and its potential use in COVID-19Portmann-Baracco A, Bryce-Alberti M, Accinelli RA (NCBI/Arch Bronconeumol/ScienceDirect) 12, 2020 | USAUse of ivermectin is associated with lower mortality in hospitalized patients with COVID-19Rajter J-C, Sherman MS, Fatteh N, Vogel F, Sacks J, Rajter J-J (ICON study; Chest) 2020 | PeruReal-world evidence: The case of Peru. Causality between ivermectin and COVID-19 infection fatality rateJuan Chamie (ResearchGate)…August 24, 2020 | BangladeshClinical trial of ivermectin plus doxycycline for the treatment of COVID-19 infectionDr. Reaz Mahmud, Dhaka Medical College (; NCT04523831) 11, 2020 | ArgentinaUsefulness of topical ivermectin and carrageenan to prevent contagion of COVID-19 (IVERCAR)Hector E Carvallo, Eurnekian Public Hospital (; NCT04425850) 9, 2020 | EgyptProphylactic Ivermectin in COVID-19 ContactsWaheed Shouman, Zagazig University (; NCT04422561) 2020 | AustraliaThe FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitroCaly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (Antiviral Res.; 178:104787) South Africa bans Ivermectin; India sends HCQ to Africa - posts by Meryl Nass, M.D. Vaccine -- posts by Meryl Nass, M.D.This blog began in 2007, focusing on anthrax vaccine, and later expanded to other public health and political issues. The blog links to media reports, medical literature, official documents and other materials.Friday, January 1, 2021First country bans ivermectin, a lifesaver for Covid--will the US be next?Ivermectin, a cheap generic drug used for hookworm, heartworm and scabies, with a half life causing it to remain in your system for months, is used as a "worming" medicine in children, dogs, horses. Due to its tremendous value as a highly safe and effective drug, a Nobel Prize was awarded to its developers in 2015.Serendipitously, it was found to be extremely effective in Covid-19, for both prevention and treatment. It is even effective at a late stage of illness, unlike hydroxychloroquine. The drug seems to work against SARS-CoV-2 even better than antimalarials. Unlike the chloroquine drugs, its efficacy was only established during the past several months. Many studies now prove its value in Covid-19.Ivermectin's routine use in places like Africa probably contributed to Africa's extraordinary resistance to Covid-19, where rates of death are a small fraction what they are in the US. Most African countries have reported death rates from Covid-19 between 1% and 10% that of the US.A US Senate hearing led by Senator Ron Johnson on December 8 called as witnesses doctors who were using the drug, who discussed its extreme benefit in the Covid epidemic.That appears to have initiated a firestorm of fake news about how the drug is dangerous, unproven, and should not be used for Covid. The Associated Press led the way, employing journalist Beatrice Dupuy, who specializes in debunking Covid 'misinformation,' and who previously wrote for Teen Vogue. The AP also used Facebook's opaque "fact checking" system. Then other media outlets followed.On Christmas Eve, 16 days after the Senate hearing that gave ivermectin its first broad publicity, the government of South Africa banned its use and importation as a treatment for Covid. No specific safety issue (except the claim the drug could kill you) was cited as the reason. There is no specific safety issue; the drug is extremely safe, although a large burden of killed worms can sometimes sicken a patient.This week, South Africa has the highest number of reported new Covid cases in Africa, per capita. Depriving them of effective treatment is obviously criminal.The chloroquine drugs are also very effective treatments for early Covid, but their use for this purpose has been obfuscated, banned, and interfered with using a huge number of techniques. I created a list of 53 different strategies that have been employed to prevent chloroquine drugs from being used against Covid in many countries. The strategies were enormously effective. Few doctors and patients have any idea that real "magic bullets" exist to cure Covid. Fewer still have realized that by preventing access to highly effective drugs, our rulers deliberately prolong the pandemic and maximize the deaths.Make no mistake: proper use of chloroquine drugs or ivermectin (all cheap and generic) would be a game changer. They would end the Covid-19 pandemic, with or without vaccines.The banning of ivermectin in South Africa is a TRIAL BALLOON--if the powers that be can get away with it there, they will start banning it elsewhere. Do everything in your power to prevent this from happening. Please spread the word. Get your doctor to prescribe the drug for you. Write letters to the newspaper. Please DO SOMETHING!UPDATE Jan 7: Police raid Durban hospital for dispensing ivermectin to patients.Posted by Meryl Nass, M.D. at 11:58 AM3 comments:Anonymous said...If cures aren't suppressed, who would bother taking the dodgy vaccines?January 2, 2021 at 6:45 AMAnonymous said...Dr. Nass,While I concur wholeheartedly that HCQ/zinc and Ivermectin treatment should both being used and that it is criminal that that they have not in so many "developed" countries, I am somewhat at a loss as to how their use would end the pandemic.Could you elaborate please?Thank you for the helpful blog.Regards,DavidJanuary 3, 2021 at 11:19 PMMeryl Nass, M.D. said...Thanks for letting me know this is not obvious.The meds work to kill virus. Normally it is said you can spread virus from one day before symptoms start till another 7-8 days. Just like for strep throat, after 1 or 2 days of rx you will no longer be able to spread the infection. That cuts the R zero (average number of people each person infects) in half (approximately) which is less than one. The pandemic dies out when each person infects less than one other person. It grows when each person infects more than one.If used prophylactically and for treatment, the pandemic would end even faster.January 4, 2021 at 7:42 PMMeryl Nass, MD(4) South African doctors call for Ivermectin to be authorised New COVID treatment may be approved – after 'urgent' court bidSome studies show that Ivermectin, a cheaply manufactured medication, can cut COVID-19 fatalities by over 80% - and AfriForum want it rolled out in SA.Tom Head by Tom Head 24-01-2021 13:02 in NewsIvermectin AfriForum COVID-19AfriForum has launched an urgent court application this weekend, as they aim to force through the use of Ivermectin – which, according to some studies, can slash COVID-19 death rates by over 80%. The lobby group believes that the time has now come to weigh 'risk against reward', and they want to see the drug fast-tracked towards approval.DOES IVERMECTIN WORK AGAINST COVID-19?As AfriForum's statement asserted, the South African Regulatory Authority for Health Products (SAHPRA) has so far failed to approve applications from medical doctors – brought under section 21 of the Medicines and Related Substances Control Act – to bring Ivermectin online as a reactionary treatment, potentially blunting the devastating impacts of the coronavirus.(5) Hydroxychloroquine is why Uganda, with a population of 43M, has only 15 COVID-19 deaths is why Uganda, with a population of 43M, has only 15 COVID-19 deathsPosted on August 19, 2020 by Dr. Eowyn | 46 CommentsUganda, a country in east-central Africa, has a 2018 population of 42.729 million, which is 13% of the United States' population of 328.239 million in 2019.And yet Uganda has 1,603 COVID-19 cases and just 15 deaths (h/t Rush Limbaugh), wherease the U.S. has 5,656,744 COVID-19 cases and 175,105 deaths. That means:Uganda's number of COVID-19 cases is only 0.028% of the number of U.S. COVID-19 cases; andUganda's number of COVID-19 deaths is only 0.008% of the number of U.S. COVID-19 deaths.How can that be, when Uganda is one of the poorest countries in the world, with a per capita GDP of $769 (37.8% of the population in 2012 lived on less than $1.25 a day) and a poor healthcare system.This is why:Uganda is afflicted with malaria, a disease caused by parasites that enter the body through the bite of a mosquito.Malaria is common in Africa. In 2012, Uganda had the 6th highest annual deaths from malaria in Africa.Hydroxychloroquine is a drug used to treat or prevent malaria — the same hydroxycholoroquine that:President Trump had taken to prevent getting COVID-19.Dr. Stella Immanuel said she had used, effectively, to treat her COVID-19 patients. A native of Nigeria, Dr. Immanuel is a physician at Rehoboth Medical Center in Houston, Texas. On July 27, 2020, with other medical professionals attending the America's Frontline Doctors Summit in front of the U.S. Supreme Court, Dr. Immanuel spoke out against the current accepted COVID-19 treatment and the need to wear masks. She said: "In the past few months, after taking in over 350 patients, we [Rehoboth Medical Center] have not lost one. Not a diabetic, not somebody with high blood pressure, not somebody with asthma, not an old person. We've not lost one patient." ( the video of Dr. Immanuel testifying to the effectiveness of hydroxychloroquine was taken down censored by Twitter, YouTube and Facebook, and denounced by Bill Gates as "outrageous". It just so "happens" that Bill Gates is developing a COVID-19 vaccine with German biotech company CureVac.Here's the banned video, thanks to Lagos Today and {visit link above}Another physician, Dr. Harvey A. Risch, writes in Newsweek: "The Key to Defeating COVID-19 Already Exists. We Need to Start Using It".Yet another physician, Dr. Brian C. Procter, also testifies to hydrochloroquine's effectiveness against COVID-19.—HCQ is simple: 2 tabs once weekly for 1 week, then 1 tab once weekly for week 2&3, then 1 tab once weekly every other week as long as necessary.—This is the biggest disinformation campaign in US History.—This is the biggest crime against American citizens in History.— Brian C. Procter MD (@ProcterMd) July 28, 2020But hydroxychloroquine is denounced by two federal agencies:Food and Drug Administration (FDA).National Institutes of Health (FIH) halted clinical trials of hydroxychloroquine, claiming the drug provided no benefits.There was a White House petition asking President Trump to sign an emergency executive order to allow over-the-counter (OTC) use of hydroxychloroquine (HCQ) to protect against COVID-19. But the petition didn't garner enough signatures. Link to petition here.H/t Anon, Laura R., Harold Saive, Vivien Lee.~Eowyn(6) India sends HCQ to Africa in war on coronavirus sends hydroxychloroquine to Africa in war on coronavirusAid initiative to fill pandemic leadership failings of China and the USMay 18, 2020 12:38 JSTMUMBAI/NEW DELHI -- India is spending around $16 million -- half of it in Africa -- on pharmaceuticals, test kits and other medical assistance for some 90 countries battling the COVID-19 pandemic.The South Asian nation has already sent consignments of hydroxychloroquine (HCQ), paracetamol and other drugs to 25 African countries at a total cost including transportation of around 600 million rupees ($7.9 million), according to a foreign ministry source."We worked out a list of essential drugs keeping their requests in mind," the official told the Nikkei Asia Review on condition of anonymity. "Transportation is a problem, but we are trying to reach them by the end of May or early June.""HCQ has a preventive use, although there is no conclusive evidence on its efficacy against coronavirus," a medical officer posted in one of the COVID-19 hospitals in New Delhi told Nikkei.According to the Indian Council of Medical Research, the anti-malarial HCQ can be used as a prophylaxis to prevent COVID-19 infection, but not as a treatment. It can be taken by doctors, health care workers and close contacts of COVID-19 cases. U.S President Donald Trump once promoted the drug as a coronavirus "game changer," but lately he has toned it down."Paracetamol is used in symptomatic care in COVID-19 cases where we see fever," the medical officer said. He noted that most of the HCQ supplied by India to Africa is going to sub-Saharan countries threatened by malaria. The World Health Organization has warned that malaria deaths could double in that region in 2020 because of disruptionns caused by the pandemic.Assistance to Africa and Latin America is the second phase of India's COVID-19 health diplomacy initiative, and follows assistance to immediate South Asian neighbors. On Mar. 15, Prime Minister Narendra Modi committed $10 million from an emergency fund to assisting seven fellow members of the South Asian Association for Regional Cooperation.India has also sent medical supplies, including masks and other types of personal protective equipment to countries around the Indian Ocean and in Central Asia, and also to six African nations.The official at the Ministry of External Affairs told Nikkei that it has committed to medical aid worth 600 million rupees for 67 countries. Procurement orders have already been placed with government agencies and state-owned companies, such as Kerala-based HLL Lifecare. The ministry is also providing financial aid to some countries and regional funds.India is donating 10 million hydroxychloroquine tablets to the 67 countries, with nearly 30% already delivered to 24 of these. Requests for medical assistance from 35 countries, mostly in Africa and West Asia, are being processed.The country's defense forces have been enlisted to help in the health diplomacy, particularly in the Indian Ocean. In early April, the Indian air force delivered 6.2 tonnes of essential medicines to the Maldives using a C-130 Hercules transport aircraft. On May 10, the Indian naval vessel INS Kesari set out for the Maldives, Mauritius, the Seychelles, Madagascar and the Comoros, with food items and medicines, including traditional Indian remedies.India is also trying to help with capacity building by offering health care training for COVID-19 management and protocols to 160 countries. It has also offered training in lockdown management to some foreign police forces. The foreign ministry official said concept papers have been invited for upgrading hospitals and vaccine centers.India has previously helped countries like Sri Lanka and the Maldives build hospitals and health care centers. "This is an opportunity for India to prove itself not only as the pharmacy to the world but also a net public health security provider," an diplomat told Nikkei.With a population of around 1.3 billion, India is facing a major battle of its own fighting COVID-19, but officials believe it can still play a global role. "Our pharma companies have the capacity to not only take care of India's needs but of other countries as well," said Harsh Pant, a professor of international relations at King's College in London.India's diplomatic play comes at a crucial juncture in international politics as the U.S. and China argue over the precise origin of the novel coronavirus amid widespread concerns over their respective shortcomings in the crisis."Through its health diplomacy, India may be trying to carve out an independent space for itself," Pant told Nikkei. "The world looks set for a new Cold War between the U.S. and China -- COVID-19 may have brought the middle power moment in international politics.""The post-coronavirus world order could create space for a group of middle powers to provide global leadership," said Gautam Bambawale, a former Indian ambassador to China. He believes Japan, India, France and South Africa are among the countries that could become more influential.(7) African countries conduct Covid trial, including HCQ 13 nations join Africa's biggest COVID treatment clinical trialCopyright © africanewsSIPHIWE SIBEKO/AFPBy Michael Oduor Last updated: 03/12 - 19:29Even as the world awaits the deployment of a COVID-19 vaccine, Africa's chances at getting a shot remains remote in the short term according to experts.That, coupled with the need to cushion health systems across the continent from being overwhelmed is the other reason for the deployment of a clinical trial named, ANTICOV – the largest trial targeting mild to moderate cases of the virus.Why the need for targeted trial According to the Drugs for Neglected Diseases Initiative, DNDi, ANTICOV's main goal "is to identify treatments that prevent mild cases from progressing to severe forms of the disease - and thus prevent local health systems from being overwhelmed.""Treating mild cases is key in Africa because ICU capacity is not as strong as may be in other developed nations," a a DNDi statement issued on November 24 stressed. The initiative is working with other partners on this project."We welcome the ANTICOV trial led by African doctors because it will help answer one of our most pressing questions: with limited intensive care facilities in Africa, can we treat people for COVID-19 earlier and stop our hospitals from being overwhelmed?" John Nkengasong, head of the African Union's Centers for Disease Control and Prevention said of the trial.Role of hydroxychloroquineHydroxychloroquine will be one of the drugs to be studied initially, because there are no large multi-country studies yet about efficacy of the drug for mild cases. HCQ remains the standard of care for COVID in 16 African countries, so this trial will provide key evidence to inform health policies and national guidelines.One of the key trials that is known to be undertaken in Africa is the World Health Organization, WHO's solidarity trials but it focuses on severe cases whiles ANTICOV will look more at mild cases with the view to nip the possible transit into severity.Thirteen countries sign upThirteen countries across the continent have signed up for the trial. The majority of these countries are in West Africa; Ghana, Guinea, Mali, Ivory Coast and Burkina Faso. East African countries include, Ethiopia, Uganda, Sudan and Kenya.Central Africa has three countries participating – Cameroon, Equatorial Guinea and the Democratic Republic of Congo. Mozambique is the sole southern African country to sign up for the trial.The clinical trial will be carried out at 19 sites continent wide by the ANTICOV consortium, which includes 26 prominent African and global research and development (R&D) organizations, coordinated by DNDi.Africa's case load as of December 2, 2020 according to Africa CDCNumber of cases = 2,196,257Number of deaths = 52,490Number of recoveries = 1,862,685Number of active cases = 386,062Most impacted country = South Africa; 790,004 casesLeast impacted country = Seychelles; 172 casesFunding for the trialMajor funding for the ANTICOV consortium is provided by the German Federal Ministry of Education and Research (BMBF) through?KfW?and by the global health agency?Unitaid?as part of?ACT-A.Early support to launch the initiative was provided by?the European & Developing Countries Clinical Trials Partnership (EDCTP),?under its second programme supported by the European Union with additional funding from the Swedish government, and the Starr International Foundation, Switzerland.(8) More than 30 trials across the world show Ivermectin effective against CovidFrom: Matthew Mitchell <>Subject: COVID-19 survival stories (using ivermectin)Real life stories of lives saved - 1st one was on ventilator about to die, then recovered when given ivermectin. further down - evidence for ivermectin described as "overwhelming":'s StoryA COVID-19 Survival story COVID-19 Survival story than 30 trials across the world show that ivermectin causes 'repeated, consistent, large magnitude improvements in clinical outcomes' in treating the disease, according to a new study.The drug is normally used to treat conditions including <> head lice and scabies.Its potential use as a treatment for Covid has been the subject of several studies since the beginning of the outbreak last year.The latest study, soon to be published in the US journal <> Frontiers of Pharmacology, claims the evidence is so strong that the drug should become a common therapy everywhere.Scientists in the research are calling on more resources to better understand the studies 'and confirm the major, positive epidemiological impacts that have been recorded when ivermectin is widely distributed among populations with a high incidence of Covid-19 infections.'The Daily Mail reports that study co-author Professor Paul Marik, director of emergency and pulmonary care at the Eastern Virginia Medical School in the US, said the data was 'overwhelming.'He was reported to have said: "We are in a pandemic, and this is an incredibly effective way to combat it."If we use ivermectin widely, our societies can open up."The Mail also reports that the drug cuts Covid infections, hospitalisations and deaths by about 75 per cent.Dr Tess Lawrie, director of the Evidence-Based Medicine Consultancy is said to have submitted a 97-page report to the World Health Organisation, urging it to recommend ivermectin to treat Covid.It has further been reported that a trial of ivermectin as a treatment for coronavirus patients is set to start soon at Oxford University.COVID-19 Management With Dr. Paul Marik - Author Of MATH+ Protocol 'If we use Ivermectin widely, our societies can open up' - Professor Paul MarikFrom: Matthew Mitchell <> than 30 trials across the world show that ivermectin causes 'repeated, consistent, large magnitude improvements in clinical outcomes' in treating the disease, according to a new study.The drug is normally used to treat conditions including <>head lice and scabies.Its potential use as a treatment for Covid has been the subject of several studies since the beginning of the outbreak last year.The latest study, soon to be published in the US journal <> Frontiers of Pharmacology, claims the evidence is so strong that the drug should become a common therapy everywhere.Scientists in the research are calling on more resources to better understand the studies 'and confirm the major, positive epidemiological impacts that have been recorded when ivermectin is widely distributed among populations with a high incidence of Covid-19 infections.'The Daily Mail reports that study co-author Professor Paul Marik, director of emergency and pulmonary care at the Eastern Virginia Medical School in the US, said the data was 'overwhelming.'He was reported to have said: "We are in a pandemic, and this is an incredibly effective way to combat it."If we use ivermectin widely, our societies can open up."The Mail also reports that the drug cuts Covid infections, hospitalisations and deaths by about 75 per cent.Dr Tess Lawrie, director of the Evidence-Based Medicine Consultancy is said to have submitted a 97-page report to the World Health Organisation, urging it to recommend ivermectin to treat Covid.It has further been reported that a trial of ivermectin as a treatment for <> coronavirus patients is set to start soon at Oxford University.(10) Interferon stops Covid Feb. 5, 2021 / 6:31 PMStudy: Hepatitis drug speeds recovery in non-hospitalized COVID-19 patientsBy Brian P. DunleavyFeb. 5 (UPI) -- A single injection of an experimental antiviral drug appears to speed recovery times in non-hospitalized patients with COVID-19, according to a study published Friday by Lancet Respiratory Medicine.In a phase 2 trial, testing whether the drug works for COVID-19 patients, those given peginterferon-lambda were four times as likely to have cleared the coronavirus infection within seven days. compared with those who received a placebo, the data showed.The drug is being evaluated for the treatment of hepatitis D, a rare form of the liver disease, according to its manufacturer, Eiger Biopharmaceuticals, of Palo Alto, Calif."This treatment has large therapeutic potential," study co-author Dr. Jordan Feld said in a statement.RELATED Inhaled form of interferon beta shows promise in COVID-19 treatment, maker saysNew treatments for COVID-19 are vital, "especially at this moment as we see aggressive variants of the virus spreading around the globe which are less sensitive to both vaccines and treatment with antibodies," said Feld, a liver specialist at Toronto Center for Liver Disease in Canada.Peginterferon-lambda is synthetic form of a protein produced by the body in response to viral infections, and it has the ability to activate a number of cellular pathways to kill invading viruses. ...(11) Medical Trial: Cheap Asthma Inhalers 90% Reduction in Severe Covid Symptoms Eric Worrall | Watts Up With That?from Aletho NewsThursday, Feb 11, 2021Queensland University and Oxford University Medical researchers investigating why asthma sufferers were "under-represented" in severe Covid cases have completed a clinical trial of Budesonide asthma inhalers. According to researchers the randomised trial was stopped early, because the results were so remarkable, the researchers did not believe it ethical to deny treatment to placebo patients. Over-the-counter inhalers suppress severe COVID symptoms, trial finds By Stuart Layt | February 10, 2021 … QUT associate professor Dan Nicolau, one of the lead researchers on the trial at the University of Oxford, said the results showed the method was extremely effective at preventing severe COVID-19 symptoms. "When we first began the trial back in March [2020], we were hoping for 50 per cent reduction [in risk of developing serious symptoms], which itself would have been very high," he said. "We got 90 per cent, which even with only a few hundred people is off the charts. "And it’s not just the overall result – their temperatures are less, they get less fever, and they recover faster." Professor Nicolau said they realised in the early stages of the pandemic that people with asthma were under-represented in severe and fatal cases of COVID-19. […] The randomised trial ended up looking at 146 patients, who were given regular doses of either corticosteroid budesonide via an inhaler, or a placebo.If other teams confirm this finding, it is a remarkable breakthrough. And confirmation should be very straightforward, given the widespread availability of this inhaler.(12) Beware of RNA-based Vaccines. Potentially Serious Injuries. The Risk of Prion Disease of RNA-based Vaccines. Potentially Serious Injuries. The Risk of Prion DiseaseBy Peter KoenigGlobal Research, March 01, 2021Remember "The Coronavirus COVID-19 Pandemic: The Real Danger is "Agenda ID2020"?,This Gates / Gavi Agenda ID2020 has already been approved by the German Parliament, without any public debate whatsoever.In Switzerland too, the government wanted to ram this infamous Agenda ID2020 through without any public debate. However, the swiss still have the constitutional right to a referendum, for which they gathered sufficient signatures to oppose Agenda ID2020 – and, would you believe, the government's plan to outsourcing its management to private companies! – The referendum will be put before a people's vote on 7 March 2021.With Swiss government's propaganda (paid for with tax-payer's money) against the referendum, propaganda carried out by the Swiss Executive which is against the Swiss Constitution, chances are that the Swiss will once more vote against their own interests. (See this)In how many other European countries will this nefarious Agenda ID2020 just be pushed through the legislative – or validated by an Executive Order – without the public at large even noticing?This is about a universal digital identification that eventually contains all – meaning ALL – personal information, including intimate private data, information from vaccinations, to health records, behavioral patterns, police records – to bank and other financial records and much more.This agenda might eventually be embedded in your body through electromagnetic substances injected with your COVID vaccine, creating an electromagnetic field, accessible through 5G technologies, the perfect surveillance equipment – see this.Dr. Barten's analysis of RNA Vaccines and the Risk of Prion DiseaseAn equally horrendous truth, the pursuit of a parallel objective, has just been revealed by Dr. J. Bart Classen, MD, Classen Immunotherapies, Inc.He published (18 January 2021) a peer-reviewed Research Paper entitled "COVID-19 RNA Based Vaccines and the Risk of Prion Disease", for the SCIVISION Publication "Microbiology & Infectious Diseases (ISSN 2639-9458) – (see this) which is the premier global open access, peer-reviewed journal that considers articles on all aspects of prevention, diagnosis and management of infectious diseases and covers the topics dealing with the epidemiology, clinical diagnosis, treatment, and control of infectious diseases.Warning: Covid Vaccines! Huge Risks, Huge Injuries – Huge Compensations?As we know by now, the current RNA-based SARS-CoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing.In Dr. Bart Classen's Research Paper, the Pfizer COVID-19 vaccine was evaluated for the potential to induce "prion"-based diseases in vaccine recipients. "Prion" is short for "proteinaceous infectious particle", in reference to its ability to self-propagate and transmit its conformation to other proteins.The peer-reviewed research article says in Dr. Bart Classen's et al, work,"the RNA sequence of the vaccine as well as the spike protein targeted interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding protein (TDP-43) and Fused in Sarcoma (FUS) into their pathologic prion conformations."In other words, do RNA-based vaccines link to DNA binding protein, causing potential medium- and long-term degenerative diseases?According to Dr. Classen, the results indicate that the RNA-based vaccine has specific sequences that may induce pathologic prion conformations.Furthermore, the spike protein, created by the translation of the vaccine RNA, may create intercellular interactions, causing ALS, front temporal lobar degeneration, Alzheimer's disease and other neurological degenerative diseases.It also may create 3 to 4 years down the road diabetes and immunity disorders.These findings, as well as additional potential risks lead the researchers to believe that regulatory approval of the RNA-based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit. For more details, see full Research Paper here.See this also.It should be also noted that Pfizer, Moderna, AstraZeneca any other RNA-based "vaccines" licensed in the US are protected from legal pursuit for injury caused by the inoculation, under the National Childhood Vaccine Injury Act (NCVIA) of 1986. In other words, they are exempt from any lawsuit resulting from vaccine injuries.To counter-balance this protection in the US, Pfizer is now seeking collateral assets from governments in Latin America, maybe also in other parts of the world, in case they may be sued because of injuries or death caused by their vaccines – imagine! It's like bullying countries in order for them to get Pfizer jabs. Read this.Isn't this saying that there is something wrong with the vaccine? Pfizer knows, their injection may do harm, maybe a lot of harm to a lot of people. Are they aware of these harmful features of the RNA-based vaccines?On another but clearly related case and presumably for similar reasons of protecting the vaccine-pharmas and the government from lawsuits, Australia has banned any medical establishment, doctors, medical personnel, pharmacies, hospitals from divulging to their patients the origin or brand of the vaccine they are being given. Fines and penalties could run as high as US$ 880,000 equivalent, plus five years in jail in case of a conviction by a court of law.What could be the reason, other than preventing vaccine injury victims from suing the vaccine companies and / or the government?Under the pretext of health protection, vaccine injuries are being played out in plain sight, in front of our eyes. And the insanity is that many people see it, but nobody stops it.Massive civil disobedience is needed by a coherent and solidary society that realizes what is at stake and what is being done to us.This may include boycotting airlines, travel agencies, theatres, concerts – and so on – if they follow the narrative of "higher orders", dictating vaccine passports for them to open the gates;Boycott transport companies and event organizers, if they want to coerce us into getting vaccinated with toxic material from which no long-term effects are known yet, but which are suspected they may be disastrous (see Dr. Bart Classen's peer-reviewed Research paper above).Disobey lockdowns and shut downs, as well as imposed compulsive testing, masking and social distancing – en masse.They are not designed to protect you from getting infected with covid – because they DO NOT protect you – but these measures are designed to harm you physically and psychologically, fracture society, break-up families, friendships, clubs, associations, school classes – it's the old "divide to conquer".See also RT's "Welcome to Snitch Nation" (27 February 2021).Foremost, beware of RNA-based so-called vaccines! They may bear long-term yet unknown incurable health consequences, including death.* Peter Koenig is a geopolitical analyst and a former Senior Economist at the World Bank and the World Health Organization (WHO), where he has worked for over 30 years on water and environment around the world. He lectures at universities in the US, Europe and South America. He writes regularly for online journals and is the author of Implosion – An Economic Thriller about War, Environmental Destruction and Corporate Greed; and co-author of Cynthia McKinney's book "When China Sneezes: From the Coronavirus Lockdown to the Global Politico-Economic Crisis" (Clarity Press – November 1, 2020)He is a Research Associate of the Centre for Research on Globalization.(13) India's low Covid mortality rate, only 35% of the global average's push to be the world's Covid-19 vaccine pharmacy24 Feb 2021|Ramesh ThakurOn 23 February, India accounted for 11 million of the world's 112 million Covid-19 cases and 156,498 of 2,848,247 world deaths. Only the US had more cases and the US, Brazil and Mexico have recorded more deaths than India. Yet India's Covid mortality rate of 113 deaths per million—only 35% of the global average of 319—places it 112th of 221 countries and other locations (including, for example, the cruise ship Diamond Princess) covered by Worldometers.I discussed India's Covid situation in the global context in an academic article in January. What's interesting since then is the extent to which India is suddenly attracting world attention. One component of this is the surprisingly low mortality rate considering the many adverse initial conditions in the country.The second is the overdue recognition that India is a vaccine superpower with a US$42 billion pharmaceutical sector, including US$20 billion worth of exports in 2019–20, a point I alluded to in a Strategist article in June. In combination with the country's emphasis on vaccine affordability and access, this gives India the potential to be the pharmacy to the world.It also gave India the self-confidence to refuse emergency-use authorisation for the Pfizer vaccine, based on trials in Germany and the US, unless it met the Indian regulator's demand for a local safety and immunogenicity study as a ‘bridging trial'. Pfizer withdrew its application.As with everything else, India does things by scale. In January, the BBC noted that India produces 60% of world vaccines by number of doses. The Guardian published an interview with Adar Poonawalla, CEO of the Serum Institute of India, the single largest manufacturer of Covid vaccines in the world by volume, on 14 February. It expects to be making 100 million doses per month by the end of March. Another company, Bharat Biotech, has the goal of making 200 million vaccines annually.Matching India's impressive private-sector manufacturing capacity scaled up to meet world needs is the emerging character of India's vaccine diplomacy. The key consideration driving the country's vaccine exports is a careful balance between world needs and demand. This echoes the government's commitment to prioritise the poor, the vulnerable and the frontline workers in the domestic vaccination drive.India has enormous experience in implementing mass-vaccination programs for smallpox, tuberculosis, polio and other illnesses. At full stretch, India will be vaccinating 85 million people per month. By 22 February, in 38 days India had vaccinated 11 million people. The goal is to cover 300 million people by the end of July.India's donations to neighbouring countries Nepal, Bangladesh, Sri Lanka, Maldives and Bhutan are nearing 6 million doses. India has pledged another 10 million doses to Africa and 1 million to UN health workers. As Indian vaccines arrived in Johannesburg, Foreign Minister S. Jaishankar tweeted on 2 February: ‘In it together. Made in India vaccines land in Johannesburg, South Africa. #VaccineMaitri' (maitri means friendship.) Afghanistan, Myanmar, Mauritius, the Seychelles, Kuwait, Morocco and Brazil are also in queue.Meanwhile, Pakistan has been the beneficiary of Chinese largesse with a donation of 1 million doses of the Sinopharm vaccine in two consignments. At the virtual meeting of the World Health Assembly on 18 May, President Xi Jinping affirmed that a coronavirus vaccine would be ‘a global public good' and represent ‘China's contribution to ensuring vaccine accessibility and affordability in developing countries'.It's worth noting that this language is a challenge to the big (by market capitalisation) Western pharmaceutical firms' drive to enforce intellectual property rights on all countries. China and India have been the leaders against that, arguing for affordable access for the people of poor countries as a higher priority. ...